KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Q3 2025 value amounting to $0.42.

  • Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) rose 11000.0% to $0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.55, marking a year-over-year increase of 9871.79%. This contributed to the annual value of $1.36 for FY2024, which is 46385.06% up from last year.
  • Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $0.42 in Q3 2025, which was up 11000.0% from $0.16 recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $0.86 during Q4 2024, and its lowest value of -$268.51 during Q4 2021.
  • For the 5-year period, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$14.92, with its median value being -$0.04 (2021).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 13529.41% in 2023, then surged by 190000.0% in 2024.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$268.51 in 2021, then skyrocketed by 99.9% to -$0.26 in 2022, then soared by 208.46% to $0.28 in 2023, then skyrocketed by 209.07% to $0.86 in 2024, then crashed by 51.39% to $0.42 in 2025.
  • Its last three reported values are $0.42 in Q3 2025, $0.16 for Q2 2025, and $0.11 during Q1 2025.